B--National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation

The National Heart, Lung, and Blood Institute (NHLBI) issued this special notice to announce its intent to award a non-competitive contract modification to Emory University. This action, conducted under the authority of FAR subpart 6.302-1, increases the ceiling of the parent award 75N92022D00015 by $49,999,999.00 to support National Institute of Biomedical Imaging and Bioengineering (NIBIB) innovation. This acquisition is classified under NAICS 541380 for Testing Laboratories and Services and PSC B599 for Special Studies/Analysis- Other.

The solicitation for this requirement, identified by number 75N92022R0117, concluded with a response deadline of August 1, 2022. An amendment was published on June 1, 2023, to officially close the pre-solicitation notice of intent to award without full and open competition. Melanie Peel serves as the primary point of contact for this requirement, which contains no associated attachments or specified set-aside designations.